V8 Peptides — Engineered Performance
CJC-1295 (No-DAC) + Ipamorelin — 5 mg / 5 mg
≥98% PURITY✓ SEQUENCE VERIFIED✓ COA AVAILABLE

CJC-1295 (No-DAC) + Ipamorelin

GHRH analog + selective secretagogue

$84.00

Size

Secure payment by card link, Zelle or crypto · discreet packaging · fast USPS shipping

Combined GHRH analog and selective GHRP blend engineered for pulsatile growth factor secretion research.

Research applications

  • 01Growth-hormone-axis signaling
  • 02GHRH & secretagogue research
  • 03Pulsatile-secretion research models
Sizes
5 mg / 5 mg · 10 mg / 10 mg
Purity
≥98%
Sequence / identity
Provided on batch COA
Supplied form
Lyophilized powder
Storage
Refrigerate at 2–8 °C; −20 °C for long-term. Protect from heat, moisture & light.
Container
Sealed clear glass research vial
≥98%
Measured purity (HPLC)
✓ Batch-specific COA published on our siteHow we test →
  • ✓Compound identity & sequence
  • ✓Measured purity (HPLC %)
  • ✓Sequence / identity confirmation
  • ✓Batch / lot number
  • ✓Analytical test date
  • ✓Supplied form & storage

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.

Batch documentation

Batch-specific analytical documentation supports receiving, verification, and internal recordkeeping.

Storage guidance

Refrigerate the supplied material, freeze for long-term storage, and protect it from heat, moisture, and light.

Research-only labeling

Every vial is clearly identified for laboratory research use only — not for human or veterinary use.

What Is the CJC-1295 (No DAC) + Ipamorelin Blend?

This product pairs two growth-hormone-axis research peptides in one co-lyophilized vial at a 1:1 mass ratio. It is available in two sizes: 5 mg of each peptide (10 mg total) or 10 mg of each (20 mg total).

CJC-1295 without DAC, also called modified GRF (1-29), is a 29-amino-acid analog of growth-hormone-releasing hormone (GHRH). Four amino-acid substitutions make it more resistant to enzymatic cleavage than native GRF (1-29). "No DAC" means the peptide lacks the drug affinity complex, the albumin-binding group found on the DAC version, so its activity window in research models is short and pulse-like. It acts at the GHRH receptor on pituitary somatotrophs.

Ipamorelin is a synthetic pentapeptide and a selective agonist of the ghrelin receptor (GHS-R1a). It is valued in endocrine research because it stimulates the growth-hormone axis with little effect on ACTH or cortisol in published animal work. Since the two peptides act through different receptors, the blend is used to study GHRH and secretagogue signaling together and to model pulsatile secretion.

Blend Specifications

ContentsCJC-1295 (No DAC) + Ipamorelin, 1:1
Vial sizes5 mg / 5 mg · 10 mg / 10 mg
Purity≥98% by HPLC
Receptor targetsGHRH receptor; ghrelin receptor (GHS-R1a)
IdentitySequence confirmation reported on the batch COA
FormCo-lyophilized powder, sealed clear glass vial
Storage2–8 °C short term; −20 °C long term

Reconstitution & Storage for Research

In a 1:1 blend each peptide is at the same mass concentration, and the total is double that figure. Check the vial size first, because the same diluent volume produces different results in the two sizes.

Concentration math

  • Adding 2 mL of diluent to the 5 mg / 5 mg vial gives 2.5 mg/mL of each peptide (5 mg/mL total).
  • Adding 1 mL of diluent to the 5 mg / 5 mg vial gives 5 mg/mL of each peptide (10 mg/mL total).
  • Adding 2 mL of diluent to the 10 mg / 10 mg vial gives 5 mg/mL of each peptide (10 mg/mL total).

Equal mass does not mean equal molarity: ipamorelin is a much smaller molecule than CJC-1295, so a 1:1 blend by mass contains several times more ipamorelin molecules. If your assay is designed in molar terms, convert using the molar mass of each peptide. The calculator covers the mg/mL step. Dissolve the cake by adding diluent against the vial wall and swirling gently.

Storage conditions

Refrigerate sealed vials at 2–8 °C and freeze at −20 °C for long-term storage, protected from heat, moisture and light. Keep reconstituted solution cold and aliquot it; short GHRH analogs lose integrity with repeated temperature cycling. Further guidance is in CJC-1295 + ipamorelin reconstitution and storage.

Quality & Testing

Both vial sizes are produced to the same specification. Each batch is analyzed by HPLC, must meet ≥98% purity, and is documented with a lot-specific certificate of analysis.

  • HPLC purity for the batch
  • Identity and sequence confirmation
  • Lot number and test date
  • Supplied form and storage statement

Certificates are posted on the COA page. For the analytical background, see CJC-1295 + ipamorelin purity testing.

Related Lab Guides

For laboratory research use only; not for human consumption.

Frequently Asked Questions

What purity is CJC-1295 (No-DAC) + Ipamorelin?+

CJC-1295 (No-DAC) + Ipamorelin is verified to ≥98% purity by HPLC, with identity confirmed by batch-specific analytical documentation (COA) published on our site.

How is CJC-1295 (No-DAC) + Ipamorelin supplied and stored?+

CJC-1295 (No-DAC) + Ipamorelin is supplied as a lyophilized powder. Refrigerate at 2–8 °C, or freeze at −20 °C for long-term storage. Protect from heat, moisture, and light.

Do you provide a Certificate of Analysis?+

Yes — every batch ships with batch-specific analytical documentation (COA) to support qualified receiving and internal recordkeeping.

Is CJC-1295 (No-DAC) + Ipamorelin approved for human use?+

No. This product is sold strictly for laboratory research and development purposes and is not for human or animal consumption.